Dr Harry Orlans Banner overlay

AOP event to discuss developments in therapeutics

Speakers at the AOP’s Therapeutics Manchester event in June include Leon Au and Dr Harry Orlans

22 Mar 2018 by Andrew McClean

The AOP’s new Therapeutics Manchester event will include lectures and workshops for independent prescriber (IP)-qualified optometrists.

Taking place at Hilton Manchester Airport Hotel on 24 June, the conference will offer attendees up to 12 interactive CET points.

It has been designed for optometrists who are working towards their therapeutics qualification, considering the IP route, or looking to make better use of the existing core competencies.

Speaking about the event, the AOP’s head of education, Dr Ian Beasley, explained to OT: “We decided to grow our portfolio of education following the success of our long-running therapeutics event in London in order to meet the needs of practitioners further north.” 

“The programme will offer the latest insight on a range of topics through lectures, workshops and peer discussion, providing up to 12 interactive points and extensive coverage of core and specialist competencies,” he added. 

The event’s morning programme includes consultant ophthalmic surgeon at the Manchester Royal Eye Hospital, Leon Au, who will tell delegates about the latest developments in glaucoma therapeutics. 

During his What’s new and what’s hot in glaucoma management lecture, Mr Au will also explore the evolution of glaucoma care delivery in the UK.

Clinical research fellow at the University of Oxford and honorary specialist registrar at Moorfields Eye Hospital, Dr Harry Orlans (pictured), will deliver his New and emerging treatments for inherited diseases of the retina lecture at the event. 

Dr Orlans will cover novel therapeutic strategies that are currently under development for the treatment of inherited diseases of the retina. He will also discuss targeted gene and optical therapies aimed at slowing or halting the progression of retina degeneration, as well as methods to restore vision to a blind eye, such as the electronic retinal implant and optogenetics.

For further information, visit the event web page.

Advertisement

Your comments

You must be logged in to join the discussion. Log in

Comments (0)